![Michael Tardugno](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Tardugno
Vorsitzender bei
IMUNON, INC.
Vermögen: 38 063 $ am 31.05.2026
Profil
Mr. Michael H.
Tardugno is an Executive Chairman at Imunon, Inc. Mr. Tardugno was previously employed as a Senior Vice President & General Manager by Mylan Technologies, Inc., an Executive Vice President by Songbird Holdings LLC, a Senior Vice President-Technical Operations by Bristol Myers Squibb Co., a Senior Vice President-Technical Operations by Convatec, Inc., a Plant Manager-Ross Laboratories Division by Abbott Laboratories, and a VP-Technology Development & Manufacturing by Bausch & Lomb, Inc. He also served on the board at THO Inc.,.
He received his undergraduate degree from St. Bonaventure University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMUNON, INC. 0.69% | 05.06.2026 | 17’460 ( 0.69% ) | 38 063 $ | 31.05.2026 |
Aktive Positionen von Michael Tardugno
| Unternehmen | Position | Beginn |
|---|---|---|
| IMUNON, INC. | Vorsitzender | 07.10.2014 |
Ehemalige bekannte Positionen von Michael Tardugno
| Unternehmen | Position | Ende |
|---|---|---|
Mylan Technologies, Inc.
 Mylan Technologies, Inc. Containers/PackagingProcess Industries Manufactures and distributes transdermal products | Geschäftsführer | 01.12.2006 |
Songbird Holdings LLC
 Songbird Holdings LLC Medical SpecialtiesHealth Technology Designs and manufactures hearing devices | Corporate Officer/Principal | 01.01.2005 |
ConvaTec, Inc.
 ConvaTec, Inc. Medical SpecialtiesHealth Technology Develops and manufactures products for the ostomy management, advanced chronic and acute wound care and continence care services | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.1998 |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Corporate Officer/Principal | 01.01.1995 |
Ausbildung von Michael Tardugno
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Mylan Technologies, Inc.
Mylan Technologies, Inc. Containers/PackagingProcess Industries Manufactures and distributes transdermal products | Process Industries |
THO Inc.,
 THO Inc., BiotechnologyHealth Technology Develops proteomic technologies | Health Technology |
ConvaTec, Inc.
ConvaTec, Inc. Medical SpecialtiesHealth Technology Develops and manufactures products for the ostomy management, advanced chronic and acute wound care and continence care services | Health Technology |
St. Bonaventure University
 St. Bonaventure University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Songbird Holdings LLC
Songbird Holdings LLC Medical SpecialtiesHealth Technology Designs and manufactures hearing devices | Health Technology |
